market access

News

NICE finds solution to making Keytruda available for TNBC

Around 100 patients in England and Wales with triple negative breast cancer (TNBC) that has spread to other parts of the body could soon access treatment with Merck & Co/MSD's Keytruda,

Market Access

Rethinking value: why diverse viewpoints matter

Value is a tricky concept to capture accurately.

Market Access

Deep Dive: Market Access

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge.

News

Closeup of X-ray photography of human brain

Biogen pulls EU application for Alzheimer's drug Aduhelm

Biogen has given up on seeking approval for its Alzheimer's disease therapy Aduhelm in the EU, saying that discussions with EU regulators had made it clear the current data for the drug is

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

ICSs - an opportunity to improve Patient & Market Access at ...

With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in the UK are preparing to navigate the most significant piece of NHS legislation in

Partner Content